Potencial antiaterogênico da bixina in vivo e in vitro

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Somacal, Sabrina lattes
Orientador(a): Emanuelli, Tatiana lattes
Banca de defesa: Bauermann, Liliane de Freitas lattes, Rodrigues, Eliseu lattes, Conterato, Greicy Michelle Marafiga lattes, Chitolina, Maria Rosa lattes
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Centro de Ciências da Saúde
Programa de Pós-Graduação: Programa de Pós-Graduação em Farmacologia
Departamento: Farmacologia
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.ufsm.br/handle/1/18021
Resumo: Atherosclerosis is a chronic disease characterized by the accumulation of lipids and fibrous elements in the intima layer of medium and large caliber arteries. Inflammation, oxidative stress as well as low density lipoprotein (LDL) oxidative modification plays an important role in the development of this disease. Thus, the inclusion of antioxidants in the diet may prevent the atherosclerosis progression. The carotenoid bixin, found in annatto seeds, has excellent antioxidant activity as demonstrated in several models of oxidative damage. In this context, the objective of this study was to evaluate the antiatherogenic potential of bixin and the mechanisms involved in this effect in models in vivo and in vitro. First, we evaluated the administration of an atherogenic diet (0.5% cholesterol) alone or supplemented with bixin (10, 30 or 100 mg/kg) or simvastatin (15 mg/kg) for 60 days in New Zealand rabbits. The atherogenic diet increased lipid serum levels, besides inducing lipid oxidation (TBARS) in aortic tissue. Supplementation with bixin or simvastatin (hypocholesterolemic reference drug) reduced serum triglycerides and TBARS levels induced by atherogenic diet in the aortic tissue but only bixin reduced the atherogenic index and increased HDL levels. Supplementation with bixin or simvastatin restored changes in NPSH levels and antioxidant enzymes activity induced by the atherogenic diet. Bixin reduced the serum levels of interleukin 6 (IL -6), tumor necrosis factor (TNF-α) and the ratio between the thickness of the intima and media in the aortic arc. Thus, the in vivo antiatherosclerotic effect of bixin seems to be associated with an improvement in the lipid profile, decreased oxidative stress and inflammatory response and prevention of changes in the antioxidant system. Considering the promising effect of bixin in vivo, in the second part of this study we investigated the possible mechanisms related to antiatherogenic effect of bixin, such as potential to prevent the oxidation of LDL in vitro and the cytotoxic effects of oxidized LDL (oxLDL) in cultured macrophages. Bixin inhibited lipid and protein oxidation of isolated human LDL in a concentration–dependent manner, and was more potent than lycopene. From 0.1 μM onwards, bixin prevented apolipoprotein B-100 (apo B-100) fragmentation, assessed by tryptophan destruction, and from 2.5 μM onwards bixin caused inhibited the formation of conjugated dienes, demonstrating that bixin has direct antioxidant effects Considering the involvement of oxLDL in the pathogenesis of atherosclerosis, we investigated the protective effect of bixin against cytotoxic damage induced by exposure of macrophages J774A.1 to oxLDL (100 μg/mL). Bixin pretreatment for 24 h reduced the cytotoxic effects triggered by oxLDL in J774A.1 macrophages in vitro, including the generation of reactive oxygen and nitrogen species, disturbance in the nitric oxide homeostasis, mitochondrial dysfunction, glutathione depletion and foam cell formation. The probable mechanisms of bixin on signaling pathways have also been investigated in cultured macrophages, demonstrating that the antiatherogenic effects of bixin are related to modulation of antioxidant and anti- inflammatory pathways through activation of Nrf2 and inactivation of NFκB pathways. Taken together, the results of this study indicate that the antiatherogenic effects of bixin are related to the prevention of LDL oxidation, improved lipid profile and cellular redox balance, as well as anti -inflammatory action and a reduction of foam cell formation and atherosclerotic lesions. These data suggest a new role for the carotenoid bixin as a potential anti-atherogenic agent.
id UFSM-20_e14a4b74914a086d68f2893648c2dcf2
oai_identifier_str oai:repositorio.ufsm.br:1/18021
network_acronym_str UFSM-20
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling 2019-08-26T15:22:50Z2019-08-26T15:22:50Z2016-08-25http://repositorio.ufsm.br/handle/1/18021Atherosclerosis is a chronic disease characterized by the accumulation of lipids and fibrous elements in the intima layer of medium and large caliber arteries. Inflammation, oxidative stress as well as low density lipoprotein (LDL) oxidative modification plays an important role in the development of this disease. Thus, the inclusion of antioxidants in the diet may prevent the atherosclerosis progression. The carotenoid bixin, found in annatto seeds, has excellent antioxidant activity as demonstrated in several models of oxidative damage. In this context, the objective of this study was to evaluate the antiatherogenic potential of bixin and the mechanisms involved in this effect in models in vivo and in vitro. First, we evaluated the administration of an atherogenic diet (0.5% cholesterol) alone or supplemented with bixin (10, 30 or 100 mg/kg) or simvastatin (15 mg/kg) for 60 days in New Zealand rabbits. The atherogenic diet increased lipid serum levels, besides inducing lipid oxidation (TBARS) in aortic tissue. Supplementation with bixin or simvastatin (hypocholesterolemic reference drug) reduced serum triglycerides and TBARS levels induced by atherogenic diet in the aortic tissue but only bixin reduced the atherogenic index and increased HDL levels. Supplementation with bixin or simvastatin restored changes in NPSH levels and antioxidant enzymes activity induced by the atherogenic diet. Bixin reduced the serum levels of interleukin 6 (IL -6), tumor necrosis factor (TNF-α) and the ratio between the thickness of the intima and media in the aortic arc. Thus, the in vivo antiatherosclerotic effect of bixin seems to be associated with an improvement in the lipid profile, decreased oxidative stress and inflammatory response and prevention of changes in the antioxidant system. Considering the promising effect of bixin in vivo, in the second part of this study we investigated the possible mechanisms related to antiatherogenic effect of bixin, such as potential to prevent the oxidation of LDL in vitro and the cytotoxic effects of oxidized LDL (oxLDL) in cultured macrophages. Bixin inhibited lipid and protein oxidation of isolated human LDL in a concentration–dependent manner, and was more potent than lycopene. From 0.1 μM onwards, bixin prevented apolipoprotein B-100 (apo B-100) fragmentation, assessed by tryptophan destruction, and from 2.5 μM onwards bixin caused inhibited the formation of conjugated dienes, demonstrating that bixin has direct antioxidant effects Considering the involvement of oxLDL in the pathogenesis of atherosclerosis, we investigated the protective effect of bixin against cytotoxic damage induced by exposure of macrophages J774A.1 to oxLDL (100 μg/mL). Bixin pretreatment for 24 h reduced the cytotoxic effects triggered by oxLDL in J774A.1 macrophages in vitro, including the generation of reactive oxygen and nitrogen species, disturbance in the nitric oxide homeostasis, mitochondrial dysfunction, glutathione depletion and foam cell formation. The probable mechanisms of bixin on signaling pathways have also been investigated in cultured macrophages, demonstrating that the antiatherogenic effects of bixin are related to modulation of antioxidant and anti- inflammatory pathways through activation of Nrf2 and inactivation of NFκB pathways. Taken together, the results of this study indicate that the antiatherogenic effects of bixin are related to the prevention of LDL oxidation, improved lipid profile and cellular redox balance, as well as anti -inflammatory action and a reduction of foam cell formation and atherosclerotic lesions. These data suggest a new role for the carotenoid bixin as a potential anti-atherogenic agent.A aterosclerose é uma doença crônica caracterizada pelo acúmulo de lipídeos e elementos fibrosos na túnica íntima das artérias de médio e grande calibre. A inflamação, o estresse oxidativo e a modificação oxidativa da lipoproteína de baixa densidade (LDL) possuem um papel importante no desenvolvimento dessa doença. Assim, a inclusão de antioxidantes na dieta poderia modular o início e a progressão da aterosclerose. O carotenoide bixina, presente nas sementes de urucum, possui excelente atividade antioxidante já demonstrada em diversos modelos de dano oxidativo. Nesse contexto, o objetivo deste estudo foi avaliar o potencial antiaterogênico da bixina e os mecanismos envolvidos neste efeito em modelos in vivo e in vitro. Primeiramente avaliou-se a administração de uma dieta aterogênica (0,5% de colesterol) sozinha ou suplementada com bixina (10, 30 ou 100 mg/kg) ou sinvastatina (15 mg/kg) por 60 dias em coelhos Nova Zelândia. A dieta aterogênica aumentou os níveis séricos de lipídios, além de induzir oxidação lipídica (TBARS) no tecido aórtico. A suplementação com bixina ou sinvastatina (medicamento hipocolesterolemiante de referência) atenuou o aumento induzido pela dieta aterogênica nos níveis de triglicerídeos séricos e nos níveis de TBARS no tecido aórtico e somente a bixina foi capaz de melhorar o índice aterogênico e aumentar os níveis de lipoproteína de alta densidade (HDL). A suplementação com bixina ou sinvastatina restaurou as alterações nos níveis de NPSH e na atividade das enzimas antioxidantes induzidas pela dieta aterogênica. A bixina reduziu os níveis séricos de interleucina 6 (IL- 6), fator de necrose tumoral (TNF-α) e a razão entre a espessura da íntima e da média no arco aórtico. Assim, o efeito antiaterosclerótico da bixina in vivo parece estar está associado a uma melhora no perfil lipídico, diminuição do estresse oxidativo e da resposta inflamatória, bem como prevenção de alterações no sistema antioxidante. Considerando o efeito promissor da bixina in vivo, na segunda parte deste estudo investigou-se in vitro os possíveis mecanismos relacionados ao efeito antiaterogênico da bixina, como: o potencial para prevenir a oxidação da LDL e os efeitos citotóxicos da LDL oxidada (LDLox) em macrófagos cultivados. A bixina inibiu de modo concentração-dependente a oxidação lipídica e proteica da LDL humana isolada, sendo mais potente que o licopeno. A partir de 0,1 μM, a bixina preveniu a fragmentação da apolipoproteína B-100 (apo B-100), avaliada através da destruição do triptofano, e a partir de 2.5 μM causou inibição significativa na formação de dienos conjugados, demostrando que a bixina possui efeitos antioxidantes diretos. Considerando o envolvimento da LDLox na patogênese da aterosclerose, investigamos o efeito protetor da bixina sobre danos citotóxicos induzidos pela exposição de macrófagos J774A.1 à LDLox (100 μg/mL). O pré-tratamento por 24 h com bixina reduziu os efeitos citotóxicos desencadeados pela LDLox em macrófagos J774A.1 in vitro, incluindo: a geração de espécies reativas de oxigênio e nitrogênio, distúrbio na homeostase do óxido nítrico, disfunção mitocondrial, depleção de glutationa e formação de células espumosas. Os prováveis mecanismos da bixina sobre vias de sinalização também foram investigados em cultura de macrófagos, demostrando que os efeitos antiaterogênico da bixina estão relacionados com a modulação das vias antioxidante e anti-inflamatória, através da ativação do Nrf2 e inativação do NFκB. Tomados em conjunto, os resultados deste estudo indicam que os efeitos antiaterogênicos da bixina estão relacionados a prevenção da oxidação da LDL, melhora do perfil lipídico e do equilíbrio redox celular, além de ação anti-inflamatória e redução na formação das células espumosas e das lesões ateroscleróticas. Esses dados sugerem um novo papel para o carotenoide bixina como potencial agente antiaterogênico.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessCarotenoidesEnzimas antioxidantesInflamaçãoLipoproteína de baixa densidade oxidada (LDLox)AteroscleroseCarotenoidsAntioxidant enzymesInflammationOxidized low density lipoprotein (LDLox)AtherosclerosisCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAPotencial antiaterogênico da bixina in vivo e in vitroAntiatherogenic potential of bixin in vivo and in vitroinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisEmanuelli, Tatianahttp://lattes.cnpq.br/2165391096880394Bauermann, Liliane de Freitashttp://lattes.cnpq.br/5849925846135968Rodrigues, Eliseuhttp://lattes.cnpq.br/0840504709593578Conterato, Greicy Michelle Marafigahttp://lattes.cnpq.br/2608761450046726Chitolina, Maria Rosahttp://lattes.cnpq.br/4401319386725357http://lattes.cnpq.br/2034988951511299Somacal, Sabrina2010000000006007812e191-0e91-4b97-bc2b-b442502f01863ecaccc4-a18d-4a8b-a7e1-a37fc0484337f89660ad-570e-4c5a-95c8-8554d6a5973130d3ae67-4cfd-4193-85c9-321b56f72a3aab869059-cd6e-446c-b6fd-455afe4aff294c1ed42a-03f5-4ced-bf2d-b4bdcf46311creponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/18021/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/18021/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53ORIGINALTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdfTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdfTese de Doutoradoapplication/pdf109068753http://repositorio.ufsm.br/bitstream/1/18021/1/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf892322e1ec953ec76000c33cb982a483MD51TEXTTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.txtTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.txtExtracted texttext/plain255942http://repositorio.ufsm.br/bitstream/1/18021/4/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.txt1505bd3dd967ba63683a1dacb4296835MD54THUMBNAILTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.jpgTES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.jpgIM Thumbnailimage/jpeg3782http://repositorio.ufsm.br/bitstream/1/18021/5/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.jpgbf9eab47c914c1c91ae4fd825e0031baMD551/180212019-08-27 03:02:45.604oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestopendoar:39132019-08-27T06:02:45Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Potencial antiaterogênico da bixina in vivo e in vitro
dc.title.alternative.eng.fl_str_mv Antiatherogenic potential of bixin in vivo and in vitro
title Potencial antiaterogênico da bixina in vivo e in vitro
spellingShingle Potencial antiaterogênico da bixina in vivo e in vitro
Somacal, Sabrina
Carotenoides
Enzimas antioxidantes
Inflamação
Lipoproteína de baixa densidade oxidada (LDLox)
Aterosclerose
Carotenoids
Antioxidant enzymes
Inflammation
Oxidized low density lipoprotein (LDLox)
Atherosclerosis
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Potencial antiaterogênico da bixina in vivo e in vitro
title_full Potencial antiaterogênico da bixina in vivo e in vitro
title_fullStr Potencial antiaterogênico da bixina in vivo e in vitro
title_full_unstemmed Potencial antiaterogênico da bixina in vivo e in vitro
title_sort Potencial antiaterogênico da bixina in vivo e in vitro
author Somacal, Sabrina
author_facet Somacal, Sabrina
author_role author
dc.contributor.advisor1.fl_str_mv Emanuelli, Tatiana
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/2165391096880394
dc.contributor.referee1.fl_str_mv Bauermann, Liliane de Freitas
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/5849925846135968
dc.contributor.referee2.fl_str_mv Rodrigues, Eliseu
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/0840504709593578
dc.contributor.referee3.fl_str_mv Conterato, Greicy Michelle Marafiga
dc.contributor.referee3Lattes.fl_str_mv http://lattes.cnpq.br/2608761450046726
dc.contributor.referee4.fl_str_mv Chitolina, Maria Rosa
dc.contributor.referee4Lattes.fl_str_mv http://lattes.cnpq.br/4401319386725357
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/2034988951511299
dc.contributor.author.fl_str_mv Somacal, Sabrina
contributor_str_mv Emanuelli, Tatiana
Bauermann, Liliane de Freitas
Rodrigues, Eliseu
Conterato, Greicy Michelle Marafiga
Chitolina, Maria Rosa
dc.subject.por.fl_str_mv Carotenoides
Enzimas antioxidantes
Inflamação
Lipoproteína de baixa densidade oxidada (LDLox)
Aterosclerose
topic Carotenoides
Enzimas antioxidantes
Inflamação
Lipoproteína de baixa densidade oxidada (LDLox)
Aterosclerose
Carotenoids
Antioxidant enzymes
Inflammation
Oxidized low density lipoprotein (LDLox)
Atherosclerosis
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.eng.fl_str_mv Carotenoids
Antioxidant enzymes
Inflammation
Oxidized low density lipoprotein (LDLox)
Atherosclerosis
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Atherosclerosis is a chronic disease characterized by the accumulation of lipids and fibrous elements in the intima layer of medium and large caliber arteries. Inflammation, oxidative stress as well as low density lipoprotein (LDL) oxidative modification plays an important role in the development of this disease. Thus, the inclusion of antioxidants in the diet may prevent the atherosclerosis progression. The carotenoid bixin, found in annatto seeds, has excellent antioxidant activity as demonstrated in several models of oxidative damage. In this context, the objective of this study was to evaluate the antiatherogenic potential of bixin and the mechanisms involved in this effect in models in vivo and in vitro. First, we evaluated the administration of an atherogenic diet (0.5% cholesterol) alone or supplemented with bixin (10, 30 or 100 mg/kg) or simvastatin (15 mg/kg) for 60 days in New Zealand rabbits. The atherogenic diet increased lipid serum levels, besides inducing lipid oxidation (TBARS) in aortic tissue. Supplementation with bixin or simvastatin (hypocholesterolemic reference drug) reduced serum triglycerides and TBARS levels induced by atherogenic diet in the aortic tissue but only bixin reduced the atherogenic index and increased HDL levels. Supplementation with bixin or simvastatin restored changes in NPSH levels and antioxidant enzymes activity induced by the atherogenic diet. Bixin reduced the serum levels of interleukin 6 (IL -6), tumor necrosis factor (TNF-α) and the ratio between the thickness of the intima and media in the aortic arc. Thus, the in vivo antiatherosclerotic effect of bixin seems to be associated with an improvement in the lipid profile, decreased oxidative stress and inflammatory response and prevention of changes in the antioxidant system. Considering the promising effect of bixin in vivo, in the second part of this study we investigated the possible mechanisms related to antiatherogenic effect of bixin, such as potential to prevent the oxidation of LDL in vitro and the cytotoxic effects of oxidized LDL (oxLDL) in cultured macrophages. Bixin inhibited lipid and protein oxidation of isolated human LDL in a concentration–dependent manner, and was more potent than lycopene. From 0.1 μM onwards, bixin prevented apolipoprotein B-100 (apo B-100) fragmentation, assessed by tryptophan destruction, and from 2.5 μM onwards bixin caused inhibited the formation of conjugated dienes, demonstrating that bixin has direct antioxidant effects Considering the involvement of oxLDL in the pathogenesis of atherosclerosis, we investigated the protective effect of bixin against cytotoxic damage induced by exposure of macrophages J774A.1 to oxLDL (100 μg/mL). Bixin pretreatment for 24 h reduced the cytotoxic effects triggered by oxLDL in J774A.1 macrophages in vitro, including the generation of reactive oxygen and nitrogen species, disturbance in the nitric oxide homeostasis, mitochondrial dysfunction, glutathione depletion and foam cell formation. The probable mechanisms of bixin on signaling pathways have also been investigated in cultured macrophages, demonstrating that the antiatherogenic effects of bixin are related to modulation of antioxidant and anti- inflammatory pathways through activation of Nrf2 and inactivation of NFκB pathways. Taken together, the results of this study indicate that the antiatherogenic effects of bixin are related to the prevention of LDL oxidation, improved lipid profile and cellular redox balance, as well as anti -inflammatory action and a reduction of foam cell formation and atherosclerotic lesions. These data suggest a new role for the carotenoid bixin as a potential anti-atherogenic agent.
publishDate 2016
dc.date.issued.fl_str_mv 2016-08-25
dc.date.accessioned.fl_str_mv 2019-08-26T15:22:50Z
dc.date.available.fl_str_mv 2019-08-26T15:22:50Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/18021
url http://repositorio.ufsm.br/handle/1/18021
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 7812e191-0e91-4b97-bc2b-b442502f0186
3ecaccc4-a18d-4a8b-a7e1-a37fc0484337
f89660ad-570e-4c5a-95c8-8554d6a59731
30d3ae67-4cfd-4193-85c9-321b56f72a3a
ab869059-cd6e-446c-b6fd-455afe4aff29
4c1ed42a-03f5-4ced-bf2d-b4bdcf46311c
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/18021/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/18021/3/license.txt
http://repositorio.ufsm.br/bitstream/1/18021/1/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf
http://repositorio.ufsm.br/bitstream/1/18021/4/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.txt
http://repositorio.ufsm.br/bitstream/1/18021/5/TES_PPGFARMACOLOGIA_2016_SOMACAL_SABRINA.pdf.jpg
bitstream.checksum.fl_str_mv 4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
892322e1ec953ec76000c33cb982a483
1505bd3dd967ba63683a1dacb4296835
bf9eab47c914c1c91ae4fd825e0031ba
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv
_version_ 1794524391357284352